CADDRA - Canadian ADHD Resource Alliance

What CADDRA - Canadian ADHD Resource Alliance does

CADDRA - Canadian ADHD Resource Alliance is a non-profit member-driven association founded in 2003 (informally since 1996, formally incorporated in 2006) and headquartered in Toronto, Canada. It serves Canadian and international healthcare professionals — including physicians (psychiatrists, pediatricians, family physicians), psychologists, mental health nurse practitioners, and allied health professionals — who assess and treat ADHD. The organization operates a 1-10 person team under Executive Director Niamh McGarry with a Board of Directors and a 20+ member Advisory Council drawn from leading Canadian universities and clinics.

CADDRA's core product is the Canadian ADHD Practice Guidelines 4.1 Edition, the only nationally recognized, independently funded ADHD clinical guidelines in Canada, updated every 2-3 years since 2006. These are delivered through a digital platform with a bilingual searchable database, fillable eToolkit forms (including ASRS, SNAP-IV-26, Weiss Symptom Record II, WFIRS), and downloadable clinical tools. Adjacent products include the ADHD TrEAT (Treatment Education and Assessment Tool) platform for screening and tracking, ADHDLearn online courses, the Canadian ADHD Medication Chart, the Psychosocial Chart, and the Step-by-Step Guide to ADHD. The member portal — built on the Joyn platform — hosts membership management, course enrollment, event registration, a member directory, and a discussion forum.

The business model is member-driven, with annual membership fees providing the base revenue, supplemented by conference/event registration (annual CADDRA Conference, ADHD Research Day, Hybrid Intensive), sales of digital guidelines ($50 non-members) and ADHD TrEAT subscriptions ($125/year non-members), grants from public/non-profit organizations (notably the 2023 Health Canada SUAP grant for CASUP), and strictly limited pharmaceutical sponsorship for conference-only activities. As of July 1, 2026, all online courses are bundled free with membership. All guideline development is independently funded with no corporate involvement, which is the organization's core credibility differentiator. Growth is driven by community-led GTM: word-of-mouth within the clinical community, conference attendance (now drawing 400+ providers from 16 countries), and advocacy visibility through partnerships with CADDAC, CanREACH, the World Federation of ADHD, and Kids Brain Health+.

Name

CADDRA - Canadian ADHD Resource Alliance

Legal name

CADDRA - Canadian ADHD Resource Alliance

Website

https://caddra.ca

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

1–10 employees

Short description

CADDRA is a Toronto-based non-profit association that develops and disseminates the Canadian ADHD Practice Guidelines, clinical tools, and accredited education to healthcare professionals across Canada and internationally.

Ownership category

akta.pro rank

Product category

Medical Practice Guidelines and Clinical Education

NAICS

Professional and Management Development Training (611430)

SIC

Services-Educational Services (8200)

akta.pro primary industry

Behavioral Health & Counseling (Social Work, Psychology, Substance Use CE) (EDAAALAD)

akta.pro secondary industry

Professional Development for Educators (Dyslexia/LD Training) (EDAKAJAK)

Keywords

• ADHD clinical guidelines
• Medical education resources
• Clinical assessment tools
• Healthcare professional training
• Continuing medical education

Headquarters

HQ city

Toronto

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Membership Fees: Annual membership fees from healthcare professionals (physicians, psychologists, allied health professionals, researchers). Members receive free or discounted access to guidelines, courses, ADHD TrEAT, and conference registration.
2. Conference and Event Registration: Revenue from annual CADDRA ADHD Conference, ADHD Research Day, and Hybrid Intensive event registrations. Members receive significant discounts on event fees.
3. Sales of Guidelines and Educational Courses: Digital ADHD Practice Guidelines sold for $50 to non-members; free PDF version. Online courses available for purchase. ADHD TrEAT sold for $125/year to non-members.
4. Grants from Public and Non-Profit Organizations: In 2023, CADDRA received its first federal grant through Health Canada's Substance Use and Addictions Program (SUAP) to develop CASUP, an online course on ADHD and substance use. CADDRA does not accept corporate funding for guideline development.
5. Pharmaceutical Industry Sponsorship (Conference Only): Limited support from pharmaceutical companies for conference sponsorship and educational grants for CADDRA-proposed projects. All industry support follows strict independence and transparency standards; sponsors have no influence over accredited program content.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels8 records

Core offering

CADDRA develops, publishes, and distributes the Canadian ADHD Practice Guidelines (4.1 Edition, 2020) and a portfolio of bilingual clinical tools—including ADHD TrEAT, ADHDLearn, CADDRA eToolkit assessment forms, the Canadian ADHD Medication Chart, and the Psychosocial Chart—for healthcare professionals in ADHD assessment and treatment. The organization additionally delivers accredited online courses, an annual ADHD Conference, ADHD Research Day, Hybrid Intensive program, Fireside Chats, and a member-only discussion forum, supported by annual professional memberships.

Product overview

CADDRA offers a unified portfolio of clinical resources, educational tools, and professional development programs centered on ADHD care for healthcare professionals. The cornerstone is the Canadian ADHD Practice Guidelines (4.1 Edition), supported by the ADHD TrEAT platform for treatment, education, and assessment, and ADHDLearn for online courses. These are complemented by practical tools including the CADDRA eTookit Forms (assessment questionnaires and scales), Step-by-Step Guide to ADHD (age-specific diagnostic flowcharts), Canadian ADHD Medication Chart (comprehensive drug reference), and Psychosocial Chart. Professional development offerings include the annual CADDRA Conference and Research Day, Hybrid Intensive program, Fireside Chats, and online courses (now free with membership as of July 2026). Member benefits include the Discussion Forum, digital guidelines access, and monthly newsletters. All offerings are directed at healthcare professionals rather than patients.

Differentiator

Problem solved

Functional benefit

Products and services

• Canadian ADHD Practice Guidelines 4.1 Edition Comprehensive, evidence-based clinical guidelines for the screening, assessment, and treatment of ADHD for healthcare professionals, developed by a multidisciplinary team of ADHD experts and updated regularly (editions in 2006, 2008, 2011, 2018, and 2020).
• ADHD TrEAT (Treatment Education and Assessment Tool) A comprehensive platform providing clinicians with self-assessment scales, fillable auto-scoring PDF forms, and clinical resources to screen, assess, and track ADHD and related conditions.

Quantifiable outcome

• Over 400 healthcare providers from 16 countries attended the 2026 Hybrid Intensive
• +1 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered core.

• World Federation of ADHDcoreStrategic or Co-development PartnerWorld Federation of ADHD is listed as a current partner of CADDRA. The partnership supports CADDRA's commitment to advancing ADHD education, research, and high-quality care across Canada by connecting with international ADHD organizations and initiatives.
• Kids Brain Health+ (formerly Kids Brain Health Network)coreStrategic or Co-development PartnerKids Brain Health+ is a current partner of CADDRA. The two organizations collaborate on the CADDRA/KBHN Junior Researcher Awards presented to student and trainee presenters at ADHD Research Day, supporting the next generation of ADHD researchers in Canada.

Scale indicators4 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• APA (American Psychiatric Association): Sets the DSM standards and publishes practice guidelines that include ADHD. Comparable as a competing clinical-authority source for the same prescriber and psychologist audience.
• Canadian Medical Association (CMA): National professional association for Canadian physicians offering continuing professional development and clinical guidance. Comparable as a broader CPD/guideline authority that overlaps with CADDRA's clinician audience.
• Royal College of Physicians and Surgeons of Canada: Canadian national specialty credentialing and continuing-education body for physicians, including psychiatrists who treat ADHD. Comparable as a continuing-education authority serving the same specialist clinicians.
• AACAP (American Academy of Child and Adolescent Psychiatry): Larger U.S. professional society covering child and adolescent psychiatry broadly, including ADHD practice parameters. Comparable as a clinical-guideline body and continuing-education provider for the same clinician audience CADDRA serves.

Direct peers

• CHADD (Children and Adults with Attention-Deficit/Hyperactivity Disorder): U.S.-based national nonprofit providing ADHD education, advocacy, and resources for individuals and professionals. Directly comparable to CADDRA as a national ADHD resource alliance with guideline-adjacent authority, member programs, and provider training.
• World Federation of ADHD: International umbrella organization for ADHD. Already a CADDRA partner; comparable in mission to advance ADHD awareness, research, and policy globally.
• CADDAC (Centre for ADHD Awareness Canada): Canadian ADHD advocacy and awareness organization, already a co-development partner with CADDRA on the Action Plan white paper. Closest domestic peer in mission and Canadian policy focus.
• CanReach / CanREACH: Canadian ADHD training program for primary care providers; already a co-development partner with CADDRA. Directly comparable as a Canadian clinician-training program in ADHD assessment and treatment.
• APSARD (American Professional Society of ADHD and Related Disorders): U.S. professional society dedicated specifically to ADHD and related disorders, focused on clinician education and research dissemination. Highly comparable as a specialty society targeting the same ADHD clinician audience.

Regional players

• ADHD UK: UK-based ADHD advocacy and information organization offering provider resources and public-facing education. Comparable structurally as a national ADHD alliance serving clinicians and the public in a single geography.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/caddra-canadian-adhd-resource-alliance

Revenue estimate

Valuation estimate

Number of profiles

Profiles16 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CADDRA - Canadian ADHD Resource Alliance